Autism research often begins with a familiar comparison: autistic people are measured against non-autistic controls. Researchers observe differences in gaze, social timing, sensory response, movement, attention, emotion recognition, interoception, or stress physiology. Those differences are then frequently described as impairments, deficits, abnormalities, or dysfunctions.

Autism research often treats difference as evidence of dysfunction. Stress biology teaches us that this is not good enough. A biological or behavioral pattern can be unusual, costly, adaptive, protective, context-dependent, or harmful and occur simultaneously— and those are not the same claim.

But a group difference is not automatically a dysfunction.

That step — from different to disordered — is an interpretation. And in many areas of autism research, this interpretation deserves more scrutiny.

Stress biology gives us a useful place to begin. In allostatic and stress-response models, biological change is not inherently pathological. A stress response can protect the organism. Heightened arousal can prepare the body for demand. Avoidance can reduce exposure to threat or overload. Immune activation can defend and repair. Mitochondrial signals can coordinate adaptation. Even patterns once viewed mainly as damage, such as certain forms of oxidative signaling, are now understood as part of normal cellular communication.

The problem is not activation itself. The problem is cost, duration, mismatch, rigidity, failed recovery, and loss of adaptive capacity.

In other words, stress biology already recognizes a distinction that autism research does not always apply carefully enough:

Atypicality is not dysfunction. Dysfunction requires evidence of harm, distress, reduced agency, failed recovery, unsustainable load, or context-independent breakdown.

This distinction matters because autistic people are often studied through environments, tasks, and expectations built around non-autistic norms. Reduced eye contact may be interpreted as social deficit, even when it functions as sensory or emotional regulation. Repetitive movement may be treated as meaningless behavior, even when autistic people describe it as soothing, communicative, organizing, or necessary. Focused interests may be framed as restricted, even when they provide meaning, expertise, predictability, and joy. Social difficulty may be located inside the autistic person, even when the problem is better understood as a mismatch between different communication styles, expectations, and sensory worlds.

None of this means that autistic people do not experience disability, distress, or serious health challenges. They do. Many autistic people experience burnout, sensory pain, exclusion, trauma, sleep disruption, gastrointestinal problems, anxiety, depression, suicidality, autonomic differences, and unmet support needs. A neurodiversity-affirming framework should not minimize those realities.

The question is where we locate the problem.

Is the trait itself dysfunctional?
Is the environment mismatched?
Is the person carrying chronic allostatic load from constant adaptation?
Is the observed behavior a regulatory strategy?
Is the difficulty produced by social misunderstanding, sensory overload, masking, trauma, or co-occurring medical conditions?
Has the study actually measured harm, or has it only measured deviation from a non-autistic norm?

This essay is the conceptual basis for a planned scoping review on what I am calling difference-to-deficit inference in autism research. The review will ask how autism studies move from observed atypicality to claims of deficit, impairment, dysfunction, abnormality, or maladaptation — and what evidence is used to justify that move.

The aim is not to dismiss biology. It is to interpret biology more carefully.

A more precise autism science would still study genetics, stress physiology, autonomic regulation, interoception, immune function, sensory processing, communication, and co-occurring medical conditions. But it would not treat deviation from the neurotypical average as sufficient evidence of defect. It would ask whether a pattern is harmful, costly, rigid, context-dependent, adaptive, protective, or simply different.

This matters especially in autism genomics and biomedical research, where interpretive framing can influence public narratives, clinical priorities, reproductive technologies, funding decisions, and community trust. If autistic traits are prematurely labeled as dysfunctions, then biological findings associated with those traits may be treated as markers of defect rather than as part of complex developmental variation.

Stress biology offers a better standard.

A trait or biological pattern should not be called dysfunctional merely because it is unusual. It should be evaluated in relation to context, cost, recovery, agency, and adaptive fit.

That is the central argument of this essay:

Autistic difference becomes disabling not because it departs from non-autistic norms, but when brain-body-environment systems generate sustained cost, constrained agency, preventable suffering, or loss of adaptive capacity.

The task for autism research is not to erase atypicality. The task is to understand when atypicality is variation, when it is adaptation, when it is overload, and when it is genuinely harmful.

That distinction is where better science begins.